Novel strategy to restore the activity of taxanes: A multicenter phase II study of combination therapy with taxanes and toremifene at 120 mg for advanced/recurrent breast cancer—Kinki Multidisciplinary Breast Oncology Group (KMBOG0612).
T. Nakayama
No relevant relationships to disclose
T. Arai
No relevant relationships to disclose
J. Yamamura
No relevant relationships to disclose
T. Morimoto
No relevant relationships to disclose
Y. Komoike
No relevant relationships to disclose
K. Yoshidome
No relevant relationships to disclose
S. Kamigaki
No relevant relationships to disclose
N. Matsunami
No relevant relationships to disclose
N. Masuda
No relevant relationships to disclose